How We Built ONE%: One Standard, Every Batch

The peptide market runs on claims that nobody documents. Long catalogues, confident language, and certificates of analysis that are always promised and rarely produced. ONE% was built as a deliberate rejection of that model. We chose a narrow range, held it to a single purity standard, and put the proof in front of the order rather than behind it. This is the story of how that standard was set, and why we treat documentation as the product rather than an afterthought.

The Conviction

Walk into most peptide suppliers and you meet the same thing. A sprawling list of compounds, marketing that leans hard on words like premium and pharmaceutical grade, and certificates of analysis that never quite materialise when you ask. Listing a compound is easy. Anyone can add a name to a page. Proving that the vial contains what the name promises, at the purity it claims, batch after batch, is the hard part, and it is the part the market routinely skips.

ONE% was built to invert that. The founding idea was almost stubbornly simple: material first, everything else second. If we could not stand behind exactly what was in the vial, with independent evidence a researcher could read before spending a cent, then it did not belong in the range. That conviction sounds obvious written down. In practice it rules out most of what the industry does.

Research integrity starts with material integrity. Everything else, the branding, the range, the site you are reading, follows from that one commitment.

Choosing The Range

A narrow catalogue is a decision, not a limitation. Every candidate compound faced the same two questions. Does the research community actually reach for this, or is it a name that pads a list? And can we hold it to a greater than 99% purity target, consistently, batch after batch, without exception? A compound had to answer both to earn a place.

What cleared the bar spans the categories that define serious peptide research: the metabolic work, from the dual-agonist Tirzepatide to the triple-agonist Retatrutide, alongside recovery, growth, skin and longevity compounds including multi-peptide blends like the KLOW matrix. Each one sits in the range because it passed the test, not because it filled a gap in a menu. If you want to see how those compounds are studied at the mechanism level, our how peptides work guide covers the underlying biology.

Vials, Not Gimmicks

Every compound ships as a classic lyophilised vial, freeze-dried for stability and reconstituted in the lab to whatever a protocol requires. We resisted the temptation to bundle. The ONE% Pen, for instance, is sold separately as a reusable instrument, because hardware you keep should never be quietly folded into the price of a compound you consume. Honest packaging is part of honest sourcing.

Proof, Not Promises

The defining decision of the brand is where we put the evidence. Every batch is submitted for independent mass-spec and HPLC analysis through third-party laboratories, and every unit is batch-referenced to its own Certificate of Analysis. Crucially, that certificate is available before you order, not produced reluctantly after a complaint. The proof leads the sale.

This is the opposite of how the industry usually treats testing, which is as a defensive document to be shown only under pressure. For ONE% it is the product. A vial without its paper trail is just a claim, and claims are exactly what we set out to replace. The full documentation programme, and how to read a certificate, lives on our lab testing and COA page.

Handling is held to the same standard. Cold-chain, discreet, EU-wide shipping is the default rather than a surcharge, because material that degrades in a warm courier depot makes a mockery of the purity figure it was tested at. The chain of custody is part of the promise.

Building The Storefront

The site you are reading was designed the same way we source: minimal, black on white, and honest. Clear documentation, plain language, and a checkout that respects your time. No countdown timers, no manufactured scarcity, no dark patterns engineered to rush a decision. The restraint of the design is not an aesthetic preference alone. It is a claim about how the whole operation behaves.

Raising the standard was never meant as a slogan about exclusivity for its own sake. It is a working commitment that shows up in the narrow range, the certificate behind every vial, and the refusal to dress up thin evidence with heavy branding. This article is simply us showing our work. When you are ready to read that work for yourself, the full range is documented compound by compound.

Frequently Asked Questions